CASE STUDY: PHARMY II AND ETHYPHARM
In April 2019 Ethypharm Group announced a definitive agreement to acquire Pharmy II Laboratory.
To reinforce its commitment to pain management, Ethypharm completed the acquisition of Pharmy II, a well stablished laboratory founded in France in 1982.
Pharmy II laboratory specialises in the treatment of pain, particularly mechanical musculo-articular pain and provides healthcare? professionals? (rheumatologists,? mesotherapists,? sports? physicians),? as? well? as? their? patients, with a range of solutions designed to be injected locally, using the mesotherapy technique.
“By entering into a new “specialised” market, Ethypharm is strengthening its commitment to pain management and its support to healthcare professionals”.
Bertrand Deluard, Ethypharm Group CEO
Read the press release here